Navigation Links
A windfall of funds for DEMO companies

As you might suspect, I'm a bit proprietary about the companies that have launched products at the DEMO conference. I am delighted when they have great news and always sorry when a company hits the bumps that inevitably pock the road of a startup. So it's a good week when so many of my "children" see the rewards for their very hard labor.

It's been a good mo......

Full article >>> w.kaboodle.com/">Kaboodle announced it had raised $3.55 million from Shea Ventures, Garage Technology Ventures and Alpha Group, along with a series of individual investors, including Kanwal Rekhi (a managing director at Inventus Capital Partners), Ashish Gupta (founder of Junglee), Dr. Rajeev Motwani (a Google advisor and Stanford University professor), Ron Conway (a well-known Valley angel).<......

Full article >>> k World Inc. All registered trademarks are owned by IDG. More information can be found at http://www.idgef.com.

Copyright 2006 IDG. All rights Reserved

The opinions expressed herein or statements made in the above column are solely those of the author, and do not necessarily reflect the views of the Wisconsin Technology Network,......

Full article >>>
'"/>

Source:wistechnology.com By Chris Shipley 04/26/06


Related biology technology :

1. Midwest colleges strong contenders for NIH funds
2. Investor links East Coast funds to Midwest tech
3. Medical College given funds for eye research
4. Superior receives funds for technical training
5. WiSys to distribute $1 million in research funds
6. New venture funds should accelerate Virents work
7. Act 255 clean-up law makes incentives work for VC funds
8. Three state tech firms win state growth funds
9. Though VC investing is down, reloading on new funds is rising
10. Florida: Investing Heavily in Biotechnology - Governor uses state funds to attract large biotech companies
11. A disgusting video: U.S. companies sell out Americans
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/28/2017)... -RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSXV: RP) (FRA:P6P2) ("RepliCel" ... clinical data from its phase 1/2 tendon repair study investigating ... (RCT-01) as a treatment for Achilles tendinosis. ... The clinical trial ... 6 months and showed no serious adverse events related to ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... fight against cancer, autoimmune disease and more through a single-cell precision engineering platform, ... proteomics analysis platform developed in the laboratory of Dr. James Heath at ...
(Date:3/27/2017)... , March 27, 2017  The global ... for 2016, according to a new report from ... lab testing is performed to evaluate disease progression, ... therapy, among other reasons.  The healthcare market research ... , provides an overview of the medical ...
(Date:3/27/2017)... ... March 27, 2017 , ... A research team ... vascular grafts in JoVE’s Video Journal, the world’s first peer-reviewed scientific video journal. ... of treating coronary artery disease (CAD). Lam is an assistant professor at the ...
Breaking Biology Technology:
(Date:3/2/2017)... March 2, 2017 Australian stem cell and ... CYP), has signed an agreement with the Monash Lung ... Biomedicine Discovery Institute and Department of Pharmacology at Monash ... further preclinical study to support the use of Cymerus™ ... Asthma is a chronic, long term ...
(Date:2/28/2017)... Feb. 28, 2017   Acuant , a leading ... announces significant enhancements to new and core technologies building ... products include mobile and desktop Acuant FRM TM ... - a real time manual review of identity documents ... provides the fastest and most accurate capture software to ...
(Date:2/28/2017)... Spanien, 27. Februar 2017  EyeLock LLC, ein marktführendes ... seine erstklassige biometrische Lösung zur Iris-Erkennung auf ... X16 LTE auf dem Mobile World Congress ... Qualcomm-Stand in Halle 3, Stand 3E10, vorstellen. ... Sicherheitsplattform Qualcomm Haven™ – eine Kombination aus ...
Breaking Biology News(10 mins):